Literature DB >> 33413358

Linc00887 suppresses tumorigenesis of cervical cancer through regulating the miR-454-3p/FRMD6-Hippo axis.

Pei Li1, Jinsheng Wang2, Lingran Zhi3, Fengmei Cai4.   

Abstract

BACKGROUND: Emerging evidence suggested that long intergenic noncoding RNA (lincRNA) 00887 (NR_024480) reduced the invasion and metastasis of non-small cell lung cancer by sponging miRNAs degradation. However, the role and regulatory mechanism of linc00887 in the progression of cervical cancer remain largely unknown.
METHODS: In vivo or vitro, RT-qPCR assay was used to detect the expression of linc00887 in human normal (N = 30), cervical cancer tissues (N = 30), human normal cervical epithelial cells (Ect1/E6E7) and cervical cancer cell lines (HeLa, C33A). Then, CCK-8 and Transwell assays were used to examine cell proliferation and invasion when linc00887 was overexpressed or knocked down. In addition, bioinformatics, luciferase reporter gene and pull-down assays were used to predict and validate the relationship between linc00887 and miR-454-3p. Moreover, we detected the expression of miR-454-3p in Ect1/E6E7, HeLa and C33A cells when linc00887 was overexpressed or knocked down. Cell proliferation and invasion were also measured when pcDNA-linc00887 and miR-454-3p were transfected alone or together. Next, miR-454-3p target gene was predicted and validated by bioinformatics and luciferase reporter gene assays. Gain- and loss-of-function experiments were performed in HeLa cells to evaluate the effect of miR-454-3p or linc00887 on the expression of FERM domain containing protein 6 (FRMD6) protein and several key proteins in the FRMD6-Hippo signaling pathway.
RESULTS: Linc00887 was downregulated in cervical cancer tissues or human cervical cancer cell lines (Hela, C33A) compared with normal tissues or cell lines. Overexpression of linc00887 inhibited proliferation and invasion HeLa and C33A cells, while linc00887 knockdown had the opposite effect. Linc00887 bound with miR-454-3p, and overexpression of miR-454-3p rescued linc00887-induced inhibition proliferation and invasion of HeLa cells. MiR-454-3p targeted and suppressed the expression of FRMD6, and linc00887 suppressed tumorigenesis of cervical cancer through activating the FRMD6-Hippo signaling pathway.
CONCLUSIONS: Linc00887, sponging miR-454-3p, inhibited the progression of cervical cancer by activating the FRMD6-Hippo signaling pathway.

Entities:  

Keywords:  Cervical cancer; FRMD6-hippo axis; RNA-ceRNA interaction; linc00887; miR-454-3p

Year:  2021        PMID: 33413358      PMCID: PMC7792119          DOI: 10.1186/s12935-020-01730-w

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  34 in total

Review 1.  The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.

Authors:  Qi Zeng; Wanjin Hong
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

Review 2.  LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years.

Authors:  Chit Tam; Jack Ho Wong; Stephen Kwok Wing Tsui; Tao Zuo; Ting Fung Chan; Tzi Bun Ng
Journal:  Appl Microbiol Biotechnol       Date:  2019-05-06       Impact factor: 4.813

3.  Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.

Authors:  Lan-Lan Feng; Fang-Rong Shen; Jin-Hua Zhou; You-Guo Chen
Journal:  Gene       Date:  2019-02-07       Impact factor: 3.688

4.  Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells.

Authors:  Wenwu Yang; Xuexian Xu; Li Hong; Qin Wang; Jinling Huang; Li Jiang
Journal:  J Cell Physiol       Date:  2019-06-17       Impact factor: 6.384

5.  miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.

Authors:  Yu Song; Qisang Guo; Shujun Gao; Keqin Hua
Journal:  Biochem Biophys Res Commun       Date:  2019-06-30       Impact factor: 3.575

6.  LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.

Authors:  Shiqing Shao; Chen Wang; Shelian Wang; Hongxia Zhang; Yongyan Zhang
Journal:  Biomed Pharmacother       Date:  2019-06-15       Impact factor: 6.529

Review 7.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Authors:  Bin Zhao; Qun-Ying Lei; Kun-Liang Guan
Journal:  Curr Opin Cell Biol       Date:  2008-11-18       Impact factor: 8.382

Review 8.  Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy.

Authors:  Diogo Estêvão; Natália Rios Costa; Rui M Gil da Costa; Rui Medeiros
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-01-29       Impact factor: 4.490

9.  Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy.

Authors:  Lili E Fodor; András Gézsi; Ldikó Ungvári; Agnes F Semsei; Zsófia Gál; Adrienne Nagy; Gabriella Gálffy; Lilla Tamási; András Kiss; Péter Antal; Csaba Szalai
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

10.  FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.

Authors:  Yin Xu; Kaiqiang Wang; Qin Yu
Journal:  Oncotarget       Date:  2016-10-25
View more
  8 in total

Review 1.  The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.

Authors:  Yi Liu; Hejing Liu; Bo Sheng; Shuya Pan; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Apoptosis       Date:  2022-08-18       Impact factor: 5.561

2.  Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC.

Authors:  Qin Yang; Lin Zhu; Mao Ye; Bin Zhang; Peihe Zhan; Hui Li; Wen Zou; Jing Liu
Journal:  Front Genet       Date:  2022-06-20       Impact factor: 4.772

Review 3.  Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease.

Authors:  Doris Chen; Wanjia Yu; Laura Aitken; Frank Gunn-Moore
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

4.  The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.

Authors:  Li Ren; Jinjin Yang; Xiyan Meng; Junjun Zhang; Yiran Zhang
Journal:  Hum Cell       Date:  2022-01-30       Impact factor: 4.174

5.  Mir-454-3p induced WTX deficiency promotes hepatocellular carcinoma progressions through regulating TGF-β signaling pathway.

Authors:  Hui Liu; Juan Zheng; Shengqian Yang; Qibei Zong; Zhiwen Wang; Xinghua Liao
Journal:  J Cancer       Date:  2022-03-21       Impact factor: 4.207

6.  Long non-coding RNAs PGM5-AS1 upregulates Decorin (DCN) to inhibit cervical cancer progression by sponging miR-4284.

Authors:  Huimin Wang; Dan Wang; Qiong Wei; Chun Li; Chunyan Li; Jing Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  LINC00887 Fosters Development of Clear Cell Renal Cell Carcinoma via Inhibiting CD8+ T Cell Immune Infiltration.

Authors:  Jinfeng Wu; Rongcheng Lin; Lei Zhang; Yongbao Wei; Ruochen Zhang; Wanghai Cai; Weilie Hu
Journal:  Comput Math Methods Med       Date:  2022-08-25       Impact factor: 2.809

8.  The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway.

Authors:  Xiao-Xing Liu; Qi-Xiu Bao; Yan-Mei Li; Yan-Hua Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.